Dr. Bostwick is Associate Chair and Clinical Associate Professor of the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy. She received her PharmD degree from the University of Michigan College of Pharmacy. Following graduation, she completed a specialty residency in psychiatric pharmacy with Kaiser Permanente in Denver, CO. At Michigan Medicine, her practice site is in adult ambulatory psychiatry. She is the Course Director of Patient Care and Communication (P506). In addition to the didactic teaching of pharmacy and nursing students, Dr. Bostwick serves as a preceptor for pharmacy students and residents. She is an active member of the College of Psychiatric and Neurologic Pharmacists (CPNP), currently serving as the Annual Meeting Director and has served as past Chair of the Program and Student Committees. Dr. Bostwick is also a member of the Rho Chi Pharmacy Honor Society and has published over 60 articles and book chapters, largely focusing in psychiatry, teaching, and the role of psychiatric pharmacists.

Research Interests

  • Metabolic monitoring in individuals treated with second generation antipsychotic medications

  • Impact of pharmacy services in psychiatry

  • Student mental health and well-being

Selected Publications

  • Dopheide J, Bostwick JR, Goldstone L, Thomas K, Nemire R, Gable K, Cates M, Caballero J, Smith T, Bainbridge J. Curriculum in psychiatry and neurology for pharmacy programs. American Journal of Pharmaceutical Education. 2017;81(7): Article 5925.

  • Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Annals of Pharmacotherapy. 2013;47(10):1330-41. doi: 10.1177/1060028013501994

  • Jasiak NM, Bostwick JR. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Annals of Pharmacotherapy. 2014;48(12):1620-8. doi: 10.1177/1060028014550645

  • Johnson JM, Wu CY, Winder GS, Casher MI, Marshall VD, Bostwick JR. The effects of cannabis on inpatient agitation, aggression, and length-of-stay. Journal of Dual Diagnosis. 2016;12(3-4):244-51. doi: 10.1080/15504263.2016.1245457

  • Lee J, Dalack GW, Casher MI, Eappen SA, Bostwick JR. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention. Journal of Clinical Pharmacy and Therapeutics 2016;41(2):209-13. doi: 10.1111/jcpt.12368

  • Gardner KN, Bostwick JR. Antipsychotic treatment response in schizophrenia. Am J Health-Syst Pharm 2012;69:1872-9.

  • Farhat NM, Bostwick JR, Rockafellow SD. Improving PGY2 ambulatory care residency training in psychiatry. Journal of Pharmacy Practice. 2017 Jan 1: 897190017729598. doi: 10.1177/0897190017729598. [Epub ahead of print].

  • Thomas SJ, Shin M, McInnis MG, Bostwick JR. Monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Pharmacotherapy. 2015;35(4):433-9. doi: 10/1002/phar.1576.